Delivery Order SPE2DB22D9765-SPE2DB23FH0GC
Award Date 1/10/23
Potential Completion Date 1/11/23
Potential Value $531
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order contract valued at two thousand eight hundred seven dollars and sixty cents ($2,807.60) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The firm fixed price order is for the delivery of four thousand five hundred fifty-nine (4,559) Boostrix Tdap vaccine syringes in 0.5mL quantities by January 13, 2023 in support of the agency's stockpile of essential medical supplies. No set-aside designation was applied to this procurement. DMS...
- This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for $2,807.60 worth of Boostrix Tdap vaccine syringes to be delivered to a location in Park Ridge, Illinois. The completion date is January 12, 2023. The contract was awarded on January 11, 2023 under a firm fixed price arrangement. No set-aside designation was used for this order. The Defense Logistics Agency manages the global supply chain for the United States military and supports procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,064.40 to DMS Pharmaceutical Group Inc. for Boostrix TDAP vaccine in syringe form (0.5ML) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois,...
- DMS Pharmaceutical Group Inc. was awarded a five-hundred-sixty-one dollar delivery order against the Defense Logistics Agency's Pharmaceutical Prime Vendor contract to supply four-hundred-fifty-nine-thousand-six-hundred-sixty-five Boostrix Tdap vaccine syringes in Park Ridge, Illinois. The 0.5mL syringes must be delivered by January 13, 2023 under a firm fixed price arrangement. No set-aside provisions were applied to this order to fulfill the Defense Logistics Agency's stockpile needs through...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,693.82 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract, effective July 23, 2025, with an ultimate completion date of July 24, 2025, represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026. No set-aside designation was applied to this award. The...
- The Defense Logistics Agency awarded a $7,580.52 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois on January 10, 2023 for 4559587191 BOOSTRIX TDAP vaccine syringes in the quantity of 0.5mL each. The order is for delivery by January 11, 2023. No set-aside provisions were applied to this award placed under an existing DLA pharmaceuticals contract vehicle. DMS Pharmaceutical Group Inc. will fulfill the order from its Park Ridge facility to supply the tetanus,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,114.52 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this contract at its facility in Park Ridge. The delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and no set-aside designation was...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on June 11, 2025, for Boostrix TDAP vaccine syringes in 0.5ml units. The contract is valued at $1,136.56 and carries a firm fixed-price structure with an ultimate completion date of June 12, 2025. This delivery order was issued without a set-aside designation, and performance will take place at the...
- The Defense Logistics Agency Troop Support Medical (DLA) awarded a $276,400 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4561543977 doses of Boostrix TDAP vaccine in 0.5mL vials. The place of performance is Park Ridge, Illinois, with deliveries required between July 13-14, 2023. DLA manages the procurement and distribution of medical supplies and equipment for all branches of the U.S. Armed Forces. This delivery order was issued against an existing DLA medical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,546.24 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The order was executed on June 18, 2025, with an ultimate completion date of June 20, 2025, and is to be performed in Park Ridge, Illinois. This delivery order was issued without set-aside designation and represents a routine pharmaceutical product fulfillment within DMS Pharmaceutical Group's broader federal supply...